GlassScriptPhysician profile
David A Dickinson
NPI 1346372687
$4,022.38
in general payments reported to CMS, 2019-2025
24 companies · $219 in 2025
The $219 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.94 · 2021: $1,866 · 2022: $1,551 · 2023: $239 · 2024: $130 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $1,720.17 | 2021-2022 | |
| Arthrex, INC. | $1,496.00 | 2021 | |
| Mallinckrodt Hospital Products INC. | $140.16 | 2022-2023 | Acthar |
| Paratek Pharmaceuticals, INC. | $128.54 | 2025 | Nuzyra |
| Ucb, INC. | $59.41 | 2023 | Cimzia |
| Organogenesis INC. | $47.68 | 2019-2023 | Puraply |
| Smith+Nephew, INC. | $45.54 | 2024 | Grafix Pl, Regranex |
| Idorsia Pharmaceuticals US INC | $41.58 | 2023-2024 | Quviviq |
| Bayer Healthcare Pharmaceuticals INC. | $36.28 | 2023 | |
| Lilly USA, LLC | $35.38 | 2022 | |
| Zimmer Biomet Holdings, INC. | $33.04 | 2021 | |
| Abbvie INC. | $23.09 | 2025 | |
| Kerecis Limited | $22.90 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Rhythm Pharmaceuticals, INC. | $20.94 | 2023 | Imcivree |
| International Life Sciences | $20.47 | 2024 | Flexband |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Oxygen Therapy INC. | $20.16 | 2024 | Topical Oxygen Chamber For Extremities |
| Treace Medical Concepts, INC. | $19.56 | 2025 | |
| Horizon Therapeutics Plc | $18.59 | 2022 | |
| Mimedx Group, INC. | $17.37 | 2024 | |
| Ebi, LLC | $16.15 | 2025 | Biomet Ebi Bone Healing System |
| Highridge Medical LLC | $16.15 | 2025 | Biomet Ebi Bone Healing System |
| Reprise Biomedical, INC. | $15.31 | 2025 | Miro3d |
| Kci USA, INC. | $14.63 | 2022 | |
| Amgen INC. | $13.28 | 2024 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dickinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.